New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials
EuroIntervention 2019;14:1788-1790 published online October 2018. DOI: 10.4244/EIJ-D-18-00767
Akram Y. Elgendy1*, MD; Islam Y. Elgendy1, MD; Mohammad K. Mojadidi1, MD; Ahmed N. Mahmoud1, MD; Julia S. Barry1, DO; Hani Jneid2, MD; Siddharth A. Wayangankar1, MD; Jonathan M. Tobis3, MD; Bernhard Meier4, MD
1. Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA; 2. Division of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX, USA; 3. Division of Cardiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA; 4. Department of Cardiology, University Hospital of Bern, Bern, Switzerland
Prior studies have shown that percutaneous patent foramen ovale (PFO) closure increases the risk of atrial fibrillation and atrial flutter (AF)1-5. Therefore, we sought to evaluate systematically the incidence of new-onset AF post percutaneous PFO closure and to determine the risk of stroke associated with new-onset AF.